DAVEN SMITH: Open Payments
NPI 1538808746 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,484 in 217 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $3,176 · 2025 $3,484
Food & beverage: $3,484
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 51 | $743 |
| Janssen Biotech, Inc. | 23 | $427 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $398 |
| Madrigal Pharmaceuticals | 13 | $330 |
| PFIZER INC. | 28 | $246 |
| Aimmune Therapeutics, Inc. | 16 | $226 |
| Phathom Pharmaceuticals, Inc. | 12 | $180 |
| Ardelyx, Inc. | 10 | $176 |
| GENZYME CORPORATION | 6 | $121 |
| Celltrion USA Inc. | 6 | $117 |
Products named: TREMFYA, ENTYVIO, RINVOQ, REZDIFFRA, DUPIXENT, VOQUEZNA, XELJANZ, IBSRELA.
Industry payments across UT — which companies pay providers there.
